Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Prenatal and Newborn Genetic Testing Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Prenatal and Newborn Genetic Testing Market Status and Forecast (2016-2027)
      • 1.3.2 Global Prenatal and Newborn Genetic Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Prenatal and Newborn Genetic Testing Supply by Company

    • 2.1 Global Prenatal and Newborn Genetic Testing Sales Value by Company
    • 2.2 Prenatal and Newborn Genetic Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Prenatal and Newborn Genetic Testing Market Status by Category

    • 3.1 Prenatal and Newborn Genetic Testing Category Introduction
      • 3.1.1 Array-Comparative Genetic Hybridization(aCGH)
      • 3.1.2 Fluorescence In-Situ Hybridization(FISH)
      • 3.1.3 Polymerase Chain Reaction(PCR)
    • 3.2 Global Prenatal and Newborn Genetic Testing Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Prenatal and Newborn Genetic Testing Market Status by End User/Segment

    • 4.1 Prenatal and Newborn Genetic Testing Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Diagnostic Organization
      • 4.1.3 Other
    • 4.2 Global Prenatal and Newborn Genetic Testing Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Prenatal and Newborn Genetic Testing Market Status by Region

    • 5.1 Global Prenatal and Newborn Genetic Testing Market by Region
    • 5.2 North America Prenatal and Newborn Genetic Testing Market Status
    • 5.3 Europe Prenatal and Newborn Genetic Testing Market Status
    • 5.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Status
    • 5.5 Central & South America Prenatal and Newborn Genetic Testing Market Status
    • 5.6 Middle East & Africa Prenatal and Newborn Genetic Testing Market Status

    6 North America Prenatal and Newborn Genetic Testing Market Status

    • 6.1 North America Prenatal and Newborn Genetic Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Prenatal and Newborn Genetic Testing Market Status

    • 7.1 Europe Prenatal and Newborn Genetic Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Prenatal and Newborn Genetic Testing Market Status

    • 8.1 Asia Pacific Prenatal and Newborn Genetic Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Prenatal and Newborn Genetic Testing Market Status

    • 9.1 Central & South America Prenatal and Newborn Genetic Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Prenatal and Newborn Genetic Testing Market Status

    • 10.1 Middle East & Africa Prenatal and Newborn Genetic Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Prenatal and Newborn Genetic Testing Market Forecast by Category and by End User/Segment

    • 12.1 Global Prenatal and Newborn Genetic Testing Sales Value Forecast (2022-2027)
    • 12.2 Global Prenatal and Newborn Genetic Testing Forecast by Category
    • 12.3 Global Prenatal and Newborn Genetic Testing Forecast by End User/Segment

    13 Global Prenatal and Newborn Genetic Testing Market Forecast by Region/Country

    • 13.1 Global Prenatal and Newborn Genetic Testing Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 WaferGen Biosystem
      • 14.1.1 Company Information
      • 14.1.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.1.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sequenom
      • 14.2.1 Company Information
      • 14.2.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.2.3 Sequenom Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Roche Diagnostic
      • 14.3.1 Company Information
      • 14.3.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.3.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Quest Diagnostic
      • 14.4.1 Company Information
      • 14.4.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.4.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Perkin Elmer
      • 14.5.1 Company Information
      • 14.5.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.5.3 Perkin Elmer Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Natera
      • 14.6.1 Company Information
      • 14.6.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.6.3 Natera Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Myriad Genetics
      • 14.7.1 Company Information
      • 14.7.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.7.3 Myriad Genetics Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Interpace Diagnostics
      • 14.8.1 Company Information
      • 14.8.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 IntegraGen
      • 14.9.1 Company Information
      • 14.9.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.9.3 IntegraGen Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Illumina
      • 14.10.1 Company Information
      • 14.10.2 Prenatal and Newborn Genetic Testing Product Introduction
      • 14.10.3 Illumina Prenatal and Newborn Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Elitech Group
    • 14.12 EKF Diagnostics
    • 14.13 Cepheid
    • 14.14 Bio-Rad
    • 14.15 Biocartis
    • 14.16 AutoGenomics
    • 14.17 Ariosa Diagnostics
    • 14.18 Agilent Technologies
    • 14.19 Abbott

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Prenatal and Newborn Genetic Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Prenatal and Newborn Genetic Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Array-Comparative Genetic Hybridization(aCGH)
      Fluorescence In-Situ Hybridization(FISH)
      Polymerase Chain Reaction(PCR)

      Segmented by End User/Segment
      Hospitals
      Diagnostic Organization
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      WaferGen Biosystem
      Sequenom
      Roche Diagnostic
      Quest Diagnostic
      Perkin Elmer
      Natera
      Myriad Genetics
      Interpace Diagnostics
      IntegraGen
      Illumina
      Elitech Group
      EKF Diagnostics
      Cepheid
      Bio-Rad
      Biocartis
      AutoGenomics
      Ariosa Diagnostics
      Agilent Technologies
      Abbott
      Buy now